Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plant Stanols and Influenza Vaccine Response
NCT05706350Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Oct 2022
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Randomised, double-blind trial (4 arms), sponsored by Maastricht University Medical Center+. Primary endpoint: Vaccine specific IgM antibody titer at 4 weeks. Started Oct 2022; status: completed.
Beyond the preview
Go deeper on NCT05706350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05706350.